GP-Act III Acquisition Corp. filed its Form 10-Q for the quarter ended September 30, 2026 with the SEC on November 16, 2026, disclosing financial results for the three and nine months ended on that date.
Key Highlights
- Trust Account balance: Marketable securities held in the Trust Account totaled $99,132,671 as of September 30, 2026, down from $309,180,211 at December 31, 2025.
- Shares subject to redemption: Class A ordinary shares subject to possible redemption stood at 8,973,728 shares at a redemption value of $11.05 per share as of September 30, 2026.
- Q3 2026 net income: The company reported net income of $581,508 for the three months ended September 30, 2026, compared to $3,105,859 in the same period of 2025.
- Nine-month net income: Net income for the nine months ended September 30, 2026 was $3,025,007, versus $8,997,926 for the nine months ended September 30, 2025.
- Shareholders' deficit: Total shareholders' deficit was $(16,615,479) as of September 30, 2026, compared to $(14,484,001) at December 31, 2025.
- Class B conversion: During the second quarter of 2026, all 7,187,500 Class B ordinary shares were converted to Class A non-redeemable ordinary shares; as of November 16, 2026, there were 9,895,034 Class A ordinary shares and 0 Class B ordinary shares outstanding.
- Promissory notes - related parties: Outstanding balance increased to $820,000 as of September 30, 2026 from $400,000 at December 31, 2025.
GP-Act III Q3 2026: Trust Drawdown and Redemptions Reshape Balance Sheet
According to the filing, GP-Act III Acquisition Corp. (NASDAQ:GPAT) reported total assets of $99,383,242 as of September 30, 2026, a significant decline from $309,368,322 at December 31, 2025. The company attributed the reduction primarily to a decrease in marketable securities held in the Trust Account, which fell from $309,180,211 to $99,132,671, reflecting substantial share redemptions over the period. Class A ordinary shares subject to possible redemption dropped from 28,750,000 to 8,973,728, with the per-share redemption value rising from $10.75 to $11.05.
The filing disclosed that interest earned on marketable securities held in the Trust Account was $897,612 for the three months ended September 30, 2026, compared to $3,232,187 in the prior-year quarter, consistent with the reduced trust balance. For the nine-month period, trust interest totaled $5,374,292 versus $9,465,640 in 2025. General and administrative expenses for the nine months ended September 30, 2026 were $2,131,478, compared to $467,714 in the same period of 2025. The company also recorded a non-redemption agreements expense of $217,807 for the nine months ended September 30, 2026, with no comparable amount in 2025.
During the second quarter of 2026, the registrant converted all 7,187,500 Class B ordinary shares into Class A non-redeemable ordinary shares, the filing stated. As of September 30, 2026, accrued expenses had risen to $1,999,237 from $233,299 at December 31, 2025. Total liabilities stood at $16,866,050, including a deferred underwriting fee payable of $13,687,500 that remained unchanged from year-end 2025. The company identified itself as a shell company and an emerging growth company in the filing.
What Was Disclosed
GP-Act III Acquisition Corp. filed its quarterly report covering the period ended September 30, 2026, disclosing a substantial reduction in trust assets due to share redemptions, conversion of all Class B shares to Class A, rising accrued expenses, and net income of $581,508 for the quarter.





Please wait processing your request...